Every Claim You Make, Every Step You Take…CVM Will Be Watching You
FDA Law Blog: Biosimilars
APRIL 7, 2025
Further, information presented on the adverse reaction data was inconsistent with the PI. The Warning Letter alleged that the veterinarian product website made claims about a Vaccine Safety Study relied upon for approval that directly conflict with the PI. that it is effective on Day 1) and insinuating misleading comparative claims.
Let's personalize your content